Ethyl 2-oxo-4-phenylbutyrate: A Key Pharmaceutical Intermediate
Unlock advanced pharmaceutical synthesis with this crucial building block for life-saving medications.
Get a Quote & SampleProduct Core Value
Ethyl 2-oxo-4-phenylbutyrate
Ethyl 2-oxo-4-phenylbutyrate, identified by CAS number 64920-29-2, is a vital aliphatic alpha-ketoester extensively utilized as a pharmaceutical intermediate. Its primary significance lies in its role as a precursor in the complex organic synthesis pathways for essential medications.
- As a key pharmaceutical intermediate, it is crucial for the synthesis of Lisinopril, an important antihypertensive drug.
- This compound also serves as a critical building block in the production of Cilastatin, aiding in the efficacy of certain antibiotics.
- The reliable ethyl 2-oxo-4-phenylbutyrate synthesis pathways ensure consistent availability for drug manufacturers.
- Understanding the correct ethyl 2-oxo-4-phenylbutyrate CAS 64920-29-2 ensures procurement accuracy and compliance.
Advantages Offered by the Product
High Purity for Reliable Synthesis
With a purity often exceeding 95%, this alpha-ketoester guarantees consistent and predictable outcomes in complex chemical synthesis, making it ideal for pharmaceutical applications.
Versatile Pharmaceutical Applications
Its proven utility in creating drugs for cardiovascular health and infectious diseases highlights its broad applicability and importance in modern medicine.
Facilitates Complex Organic Synthesis
As a key intermediate, it streamlines the production of advanced therapeutic agents, simplifying challenging chemical transformations.
Key Applications
Pharmaceutical Manufacturing
Essential for the synthesis of crucial drugs like Lisinopril, contributing to cardiovascular health management.
Antibiotic Adjuvant Production
Plays a vital role in producing Cilastatin, which enhances the effectiveness of certain antibacterial agents.
Organic Chemistry Research
Serves as a valuable building block for various research projects in organic synthesis, exploring new chemical entities.
Drug Development
Supports the development pipeline for new pharmaceuticals, acting as a key intermediate in novel drug discovery.